Cell Surgical Network Corporation — Department of Defense SBIR Phase II: AF211-DCSO1
Cell Surgical Network Corporation — SBIR Phase II award from Department of Defense.
- Amount
- $750,000
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase II
- Topic
- AF211-DCSO1
- Solicitation
- X21.1
- NAICS
- —
- Place of performance
- CA
- Period
- 2022-08-04 → 2023-11-07
Description
Objectives To evaluate the safety of autologous adipose-derived stromal vascular fraction (SVF) for the mitigation of symptoms of blast traumatic brain injury (bTBI) in affected combat veterans exhibiting symptoms of posttraumatic stress disorder (PTSD) that have had exposure to military grade blast explosions. Secondly, to evaluate the efficacy of SVF for bTBI against a control group.